TRIM9
E3 ubiquitin-protein ligase TRIM9
Also known as: RNF91, SPRING, TRIM9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9C026
- Gene
- TRIM9
- Ensembl
- ENSG00000100505
- Chromosome
- 14
- Canonical length
- 710 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. Its function has not been identified. Alternate splicing of this gene generates two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
710 residues, UniProt reviewed canonical sequence.
>Q9C026|TRIM9
1 MEEMEEELKC PVCGSFYREP IILPCSHNLC QACARNILVQ TPESESPQSH RAAGSGVSDY
61 DYLDLDKMSL YSEADSGYGS YGGFASAPTT PCQKSPNGVR VFPPAMPPPA THLSPALAPV
121 PRNSCITCPQ CHRSLILDDR GLRGFPKNRV LEGVIDRYQQ SKAAALKCQL CEKAPKEATV
181 MCEQCDVFYC DPCRLRCHPP RGPLAKHRLV PPAQGRVSRR LSPRKVSTCT DHELENHSMY
241 CVQCKMPVCY QCLEEGKHSS HEVKALGAMW KLHKSQLSQA LNGLSDRAKE AKEFLVQLRN
301 MVQQIQENSV EFEACLVAQC DALIDALNRR KAQLLARVNK EHEHKLKVVR DQISHCTVKL
361 RQTTGLMEYC LEVIKENDPS GFLQISDALI RRVHLTEDQW GKGTLTPRMT TDFDLSLDNS
421 PLLQSIHQLD FVQVKASSPV PATPILQLEE CCTHNNSATL SWKQPPLSTV PADGYILELD
481 DGNGGQFREV YVGKETMCTV DGLHFNSTYN ARVKAFNKTG VSPYSKTLVL QTSEVAWFAF
541 DPGSAHSDII LSNDNLTVTC SSYDDRVVLG KTGFSKGIHY WELTVDRYDN HPDPAFGVAR
601 MDVMKDVMLG KDDKAWAMYV DNNRSWFMHN NSHTNRTEGG ITKGATIGVL LDLNRKNLTF
661 FINDEQQGPI AFDNVEGLFF PAVSLNRNVQ VTLHTGLPVP DFYSSRASIALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRIM9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 46 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 46 nTPM
- retina: 22 nTPM
- cerebellum: 21 nTPM
- hippocampal formation: 14 nTPM
- amygdala: 14 nTPM
- basal ganglia: 14 nTPM
Single-cell type
- oligodendrocyte progenitor cells: 805 nCPM
- pituicytes/fscs: 660 nCPM
- brain excitatory neurons: 594 nCPM
- astrocytes: 499 nCPM
- bergmann glia: 493 nCPM
- brain inhibitory neurons: 480 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 185 nTPM
- hippocampal formation: 146 nTPM
- cerebral cortex: 144 nTPM
- basal ganglia: 116 nTPM
- white matter: 114 nTPM
- amygdala: 110 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TRIM9.
Disease | ImmuneIEDB
Conditions an epitope on TRIM9 was assayed in.
- encephalitis B cell
- lung adenocarcinoma B cell
ReferencesPubMed · IEDB
Publications for TRIM9 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.
2023 · Ann Neurol · RCR 1.3 · 11 citations - Teaching NeuroImage: Paraneoplastic Cerebellar Degeneration and Antibodies to TRIM 9 and 67 Secondary to Melanoma.
2023 · Neurology · RCR 0.2 · 2 citations
Reference: B cellIEDB
1 publication
- Detection of High-Risk Paraneoplastic Antibodies against TRIM9 and TRIM67 Proteins.
2023 · Ann Neurol · RCR 1.3 · 11 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.01
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- protein domain specific binding
- protein homodimerization activity
- ubiquitin protein ligase activity
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B-box-type zinc finger
- Zinc finger, RING-type
- B30.2/SPRY domain
- B-box, C-terminal
- SPRY domain
- Fibronectin type III
- Zinc finger, RING/FYVE/PHD-type
- Concanavalin A-like lectin/glucanase domain superfamily
- Immunoglobulin-like fold
- COS domain
- Zinc finger, RING-type, conserved site
- Zinc finger, C3HC4 RING-type
- Fibronectin type III superfamily
- B30.2/SPRY domain superfamily
- E3 ubiquitin-protein ligases and FN3/SPRY domain-containing proteins
- Fibronectin type III domain
- Zinc finger, C3HC4 type (RING finger)
- SPRY domain
- B-box zinc finger
- ANCHR-like B-box zinc-binding domain
- Tripartite motif-containing protein 9, B-box-type 1 zinc finger
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRIM9 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRIM9 as an antibody target. Whether an autoantibody or antibody against TRIM9 could matter depends on whether native TRIM9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRIM9 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRIM9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...